Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06314529
Long-term Follow-up Study of BHC001 for TDT
Sponsor: Bioray Laboratories
View on ClinicalTrials.gov
Summary
Observe long-term safety risk and long-term efficacy after intravenous infusion of BHC001 in TDT subjects.
Official title: Long-term Follow-up Study of BHC001 in the Treatment of Transfusion-dependent β-thalassemia
Key Details
Gender
All
Age Range
5 Years - 35 Years
Study Type
OBSERVATIONAL
Enrollment
6
Start Date
2022-12-14
Completion Date
2037-05-10
Last Updated
2024-03-18
Healthy Volunteers
No
Conditions
Interventions
OTHER
Assessments
Safety and efficacy assessments
Locations (2)
The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army
Nanning, Guangxi, China
Xiangya Hospital of Central South University
Changsha, Hunan, China